JAN 27, 2019 12:38 PM PST

Why Lithium Can Have a Negative Impact on the Kidney

WRITTEN BY: Carmen Leitch

An international team of researchers has found that an enzyme called Glycogen Synthase Kinase 3 (GSK3), known to be reduced by lithium intake, is an essential regulator of cell function in the kidneys. In blood-filtering podocyte cells of the kidney, there are two forms of the GSK3 enzyme (α and β), which stop proteins like albumin from leaking into the urine. That helps prevent kidney failure. If both forms of the enzyme are reduced during development or in adults, it can increase the likelihood of renal failure. The work, by an international team led by researchers at the University of Bristol, has been reported in Nature Communications and can explain why lithium is associated with renal problems.

"We think that patients who are taking lithium treatment now should regularly have a simple urine test to measure the amount of albumin they are excreting, as too much albumin is a sign of kidney disease," said the lead author of the study Richard Coward, a Professor of Renal Medicine and Consultant Pediatric Nephrologist at Bristol Medical School and the Bristol Royal Hospital for Children and the University of Bristol.

Lithium, a drug commonly used to treat bipolar disorder and other conditions, is known to suppress GSK3. When people have to take lithium over long periods or at high doses, they might start leaking high amounts of protein into their urine. The kidneys in those individuals may then begin to fail, leading them to require dialysis or a transplant.

"If [patients taking lithium] have increased levels of protein in their urine, they should consider reducing [the] dose of their lithium or switching medications. We think this could prevent some of them from developing kidney failure. Our research further suggests that it would be sensible to try and develop drugs that selectively inhibit one of the two forms of GSK3,” said Coward.

In this work, the researchers used a mouse model to show that losing both forms of GSK3 beta was highly detrimental to podocytes. The same has also been seen in neurons, but for a different reason. Losing GSK3 was causing podocytes, which are terminally differentiated, to re-enter the cell cycle, damaging these cells beyond repair. Their mouse model lacking GSK3 in podocytes only survived for a few weeks after birth and developed kidney disease.

GSK3 inhibitors have been considered as a treatment for other diseases including Alzheimer's and cancer. It's been suggested that disrupting GSK3 in podocyte cells may be a good treatment for kidney disease. The scientists involved in this work suggested that pharmaceutical companies should use caution, however, when developing these therapeutics. 

This is a transmission electron microscopic picture of the filtration barrier of the kidney- foot processes of podocytes shown throughout. / Credit: Richard Coward

Next, the researchers want to learn more about cellular pathways that are impacted by GSK3 in podocytes. They plan to explore which versions of the enzyme (α and β) are involved in which pathways. 


Sources: AAAS/Eurekalert! via University of Bristol, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 19, 2019
Cell & Molecular Biology
NOV 19, 2019
Neurons That Keep us Awake During the Day are Destroyed by Alzheimer's
Alzheimer’s disease is a devastating degenerative disorder thought to affect around 5.5 million Americans, most of whom are over the age of 65....
NOV 19, 2019
Genetics & Genomics
NOV 19, 2019
Detecting DNA - Without Amplification
As genetic technologies rapidly advance, totally new approaches are now possible. One innovation is the CRISPR-Chip....
NOV 19, 2019
Cell & Molecular Biology
NOV 19, 2019
We are Changing the Shape of Our Dogs Brains
Scientist look at the differences of brains between dog breeds. This may be caused by breeding for unique traits between breeds....
NOV 19, 2019
Cell & Molecular Biology
NOV 19, 2019
Irritable Bowel Syndrome Gut Pain is Traced Back to Itch Receptors
Researchers have IDed nervous system receptors that can activate neurons and cause a painful feeling of itchy gut, often described by IBS patients....
NOV 19, 2019
Cell & Molecular Biology
NOV 19, 2019
Scientists Create a New Version of CRISPR - Prime Editing
A new technique enables researchers to target and modify one base pair out of billions, and could correct disease-causing mutations....
NOV 19, 2019
Cell & Molecular Biology
NOV 19, 2019
The Different Signals Sent by Brown and White Fat
Scientists have now learned more about the molecules that brown fat releases....
Loading Comments...